Xiaoxuan Wang

发表

Comprehensive identification of FGFR1-4 alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing.

Yong Wang, Xuchao Zhang, Furong Du, 2021, American journal of cancer research.

Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors.

Junyi Wang, Jiaqi Li, Geer Chen, 2022, Pharmacological research.

Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling

I. Hyodo, K. Yamato, Yoshiyuki Yamamoto, 2021, Oncology letters.

Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: a case report and literature review

Dawei Liu, Xu Zheng, Jianping Chu, 2022, BMC Pediatrics.

OPA1 supports mitochondrial dynamics and immune evasion to CD8+ T cell in lung adenocarcinoma

Y. Wang, Jixiang Wu, Yayun Gu, 2022, PeerJ.

Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: a systematic review and meta-analysis.

Furong Du, Nanya Wang, Yong Qin, 2022, Gene.

TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma

Tianzhu Qiu, Furong Du, Fujun Sun, 2022, World Journal of Surgical Oncology.

MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53

I. Hyodo, K. Yamato, Yoshiyuki Yamamoto, 2021, AntiCancer Research.

Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis.

F. Xue, Hui Xue, Lei Zhang, 2023, Annals of hepatology.

Augmented antitumor activity of 5‐fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells

I. Hyodo, K. Yamato, Yoshiyuki Yamamoto, 2019, Cancer science.